Ocean Biomedical Inc.

07/23/2025 | Press release | Distributed by Public on 07/23/2025 15:28

Failure to Satisfy Listing Rule (Form 8-K)

Item 3.01 Notice of Delisting

On July 17, 2025, Ocean Biomedical, Inc. (the "Company") received the decision of the Nasdaq Listing and Hearing Review Council (the "Listing Council") pursuant to an appeal by the Company. On April 22, 2025, the Nasdaq Hearings Panel (the "Panel") issued a decision to delist the Company's securities from The Nasdaq Stock Market, LLC (the "Exchange" or "Nasdaq") and suspend trading of the Company's shares, effective at the opening of business on April 24, 2025. The Company appealed the Panel's decision to the Listing Council. After considering the written record in this matter, the Listing Council affirms the Panel's decision to delist the Company from the Nasdaq affirming Nasdaq's delist decision letter dated April 22, 2025.

Ocean Biomedical Inc. published this content on July 23, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on July 23, 2025 at 21:28 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]